Soliqua 100/33 (insulin glargine and lixisenatide)

**Product type:** Human Prescription Drug

**Active ingredient:** INSULIN GLARGINE; LIXISENATIDE

**Strength:** 100; 33 U/mL; ug/mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Sanofi-Aventis U.S. LLC

**Marketing category:** BLA (BLA208673)

**Pharmacologic class:** GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Insulin Analog [EPC], Insulin [CS]